- 創業 - MIT-CHIEF 8/17 泰州9/14
- BTBA 8/5, 6 玉山科協 8/12
- 波士頓哲五 - 國家正常化與青年組織
- 客家鄉親會烤肉8/5 TCCNE高爾夫球 8/6
- 波士頓同源會 8/19 昆士市中秋節 8/20
- 崇德佛院 普賢講堂 慈濟
- 招聘 - 波士頓僑教中心，中山醫學院，孫逸仙紀念醫院 Chicken & Rice Guy
- 波士頓同源會頒獎宴8/19 夏星朗讀會誌記梭羅200週年8/26
- ILF 國際領袖基金會
- ILF 國際領袖基金會 - ACE Next generation conference 8/18-20
- 麻州州長動態 - Awarded $14M
- 羅德島州克蘭斯頓市長馮偉傑 Car Tax Bill
- 劍橋市議員張禮能 - Say thanks and farewell
- City of Boston, Quincy, Malden, Greenway 昆市市長亞裔顧問委員會
- MIT ENERGY CLUB Mass Innovation Nights
- 博物館 - Guggenheim, Harvard Art, Forbes House, China Institute
- Plays - Where Am I 8/23 爬藤9/16 Ideation 9/2-24
- MIPIM 2017 - Real Estate Tech Trends from MIPIM
- 李保華忠告年輕人 做個遠大的夢
- 朱学渊 - 陈建奇、郭晓敏：特朗普重塑全球的三大战略
- 作者專欄： 王世輝 - 看見台灣：向齊柏林致敬
- 台灣工程師的矽谷故事- 兩份文件，與嫁衣台灣
- HCSSA - 幹部改選結果公佈
- 【你的學歷，能幫助公司什麼…？】如果沒有這 7 個特質，你讀到台大也沒用！
- 校友、同學會 、北一女、建中 8/19 北美洲成大校友10/13-15 北大，清華，中科大， CYPN
- 牛頓市議員馬惠美- 和選民見面會8/5, 8/16
- 劍橋市素描餐廳 8/9 慶祝世界白酒日
- 波士頓市議會議長吳弭 (Michelle Wu ) - 8/6 啟動連任競選
- BIOVision/ Boston MedTech / Mass Life Sciences
- Ben Chin for Mayor in Maine
- BCIC - Fintech Roundtable Brainstorming Session 7/...
星期四, 5月 05, 2016
Allurion Technologies’ Elipse™ Intragastric Balloon Receives Prestigious SAGES Innovation Award
announced today that its flagship product, Elipse, has received the prestigious Emerging Technology Innovation Award from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Elipse is the world’s first procedureless™ intragastric balloon: it is placed and removed without surgery, endoscopy or anesthesia. It is the first intragastric balloon to receive this award. Elipse received European Union CE marking in late 2015 and is now available at leading weight loss centers in the United Kingdom, Italy and France. Plans for commercial expansion within Europe and in the Middle East are underway. Elipse is not yet approved by the FDA and is not available in the United States.
Elipse was one of 13 technologies chosen to present to an expert panel of gastrointestinal and endoscopic surgeons. The panel voted Elipse the top emerging technology of SAGES 2016 following a presentation by Allurion Co-Founder and Chief Scientific Officer Dr. Shantanu Gaur. “We are honored that our novel approach to weight loss has been recognized by the physicians of SAGES,” said Dr. Gaur. “This award adds to our momentum as we expand awareness of Elipse among physicians and consumers.”
"The medical community has been looking for innovative tools like Elipse to aid in the fight against overweight and obesity” said Jonathan Wecker, Chief Executive Officer of Allurion. “Without the cost and invasiveness of surgery, endoscopy and anesthesia, this new option vastly expands access to intragastric balloons.”
Allurion Co-Founder and President Dr. Samuel Levy added that “physicians and consumers involved in our initial European launch have been extremely pleased, and we look forward to continued success as Elipse is rolled out to new weight loss centers and new geographies."
Elipse is a procedureless intragastric balloon: it is placed and removed without surgery, endoscopy or anesthesia. It is offered by physicians in conjunction with a medically supervised weight loss program. The Elipse balloon is made of a thin, flexible polymer film. The device is swallowed in a capsule and filled with liquid through a thin delivery catheter, which is then detached. Elipse remains in the stomach for approximately four months after which the balloon opens, allowing it to empty and pass naturally from the body. A clinical study of Elipse in individuals with a Body Mass Index (BMI) between 27 and 40 showed an average weight loss of 10 kilograms (22 pounds), with participants losing 39 percent of their excess weight and eight centimeters from their waist circumference. Participants also saw improvements in their triglycerides, haemoglobin A1c (HbA1c) and quality of life. Learn more and see an animation of Elipse in action .
is dedicated to developing less invasive treatments for overweight and obese individuals. The company's flagship product, Elipse, is an intragastric balloon that resides in the stomach, enabling weight reduction. Allurion is funded by private investors and the Massachusetts Life Sciences Center. Learn more about Elipse and Allurion online at or on Twitter .